tavaborole

Generic: tavaborole

Labeler: mayne pharma commercial llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tavaborole
Generic Name tavaborole
Labeler mayne pharma commercial llc
Dosage Form SOLUTION
Routes
TOPICAL
Active Ingredients

tavaborole 43.5 mg/mL

Manufacturer
Mayne Pharma Commercial LLC

Identifiers & Regulatory

Product NDC 51862-690
Product ID 51862-690_12ed0433-3ec5-f721-e063-6294a90adc2b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211297
Listing Expiration 2026-12-31
Marketing Start 2021-02-01

Pharmacologic Class

Established (EPC)
oxaborole antifungal [epc]
Mechanism of Action
protein synthesis inhibitors [moa]
Chemical Structure
boron compounds [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51862690
Hyphenated Format 51862-690

Supplemental Identifiers

RxCUI
1543177
UPC
0351862690107
UNII
K124A4EUQ3
NUI
N0000191279 N0000000150 M0002832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tavaborole (source: ndc)
Generic Name tavaborole (source: ndc)
Application Number ANDA211297 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 43.5 mg/mL
source: ndc
Packaging
  • 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Tavaborole topical solution, 5% is a clear, colorless solution supplied in an amber glass bottle with a screw cap. At initial use, the screw cap is replaced with the dropper assembly. Tavaborole topical solution, 5% is supplied in the following presentations: NDC 51862-690-10: One bottle containing 10 mL of solution with one glass pointed-tip dropper. The Packaging of This Product Contains Dry Natural Rubber. 16.2 Storage and Handling Store at 20–25°C (68–77°F); excursions permitted to 15–30°C (59–86°F) [see USP Controlled Room Temperature]. CAUTION: Flammable. Keep away from heat and flame. Discard product within 3 months after insertion of the dropper. Keep bottle tightly closed. Keep out of reach of children.
  • PRINCIPAL DISPLAY PANEL - 10 mL Bottle Label NDC 51862-690-10 Tavaborole Topical Solution, 5% For Topical Use Only Not for oral, ophthalmic, or intravaginal use Rx Only 10 mL mayne pharma tavaborole-06
source: label

Packages (0)

No package records.

Ingredients (1)

tavaborole (43.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "12ed0433-3ec5-f721-e063-6294a90adc2b", "openfda": {"nui": ["N0000191279", "N0000000150", "M0002832"], "upc": ["0351862690107"], "unii": ["K124A4EUQ3"], "rxcui": ["1543177"], "spl_set_id": ["7ad9dc39-7501-4db5-a935-d9be8eea30a6"], "pharm_class_cs": ["Boron Compounds [CS]"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Mayne Pharma Commercial LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "tavaborole", "product_id": "51862-690_12ed0433-3ec5-f721-e063-6294a90adc2b", "dosage_form": "SOLUTION", "pharm_class": ["Boron Compounds [CS]", "Oxaborole Antifungal [EPC]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "51862-690", "generic_name": "tavaborole", "labeler_name": "Mayne Pharma Commercial LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tavaborole", "active_ingredients": [{"name": "TAVABOROLE", "strength": "43.5 mg/mL"}], "application_number": "ANDA211297", "marketing_category": "ANDA", "marketing_start_date": "20210201", "listing_expiration_date": "20261231"}